The dramatic follicle enlargement seen in rodent models doesn't automatically translate to equivalent effects in humans with years of miniaturization already established
Compliance / Safety NOT FOR HUMAN OR VETERINARY USE
The next, phase 1b clinical trial in adults with T2DM compared once weekly retatrutide (0.5, 1.5, 3, 3 mg starting dose increased to 6, 3 mg starting dose increased to 12 mg) versus placebo versus dulaglutide 1.5 mg over 12 weeks [63]
Mitochondrial energy production pathway (MEPP) is a major source of oxygen radicals
2-4 Healthcare professionals are encouraged to screen for dysglycaemia to help prevent the development of diabetes and its associated complications
We do not have enough evidence to safely prescribe under 12 at this point, for obesity, Dr